Dengue drug trial pulled before it even started
NCT ID NCT03875560
First seen May 09, 2026 · Last updated May 12, 2026 · Updated 1 time
Summary
This study was designed to test an experimental drug called IC14 in adults with early dengue fever. The goal was to check if the drug is safe and might help reduce fever and virus levels. However, the trial was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE FEVER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.